Market Cap

TaiRx, Inc. Market Capitalization:

TW$4.25 Billion

TWD as of July 1, 2024

US$130.5 Million

business TaiRx, Inc. Company Profile

TaiRx, Inc. Main Stock Listing

TWSE: 6580

Market Capitalization History of TaiRx, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of TaiRx, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$2.85 B -9.51%
Jan. 1, 2023 TW$3.15 B -56.38%
Jan. 1, 2022 TW$7.22 B 197.03%
Jan. 1, 2021 TW$2.43 B 42.10%
Jan. 1, 2020 TW$1.71 B -20.74%
Jan. 1, 2019 TW$2.16 B -17.85%
Jan. 1, 2018 TW$2.63 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

TaiRx, Inc. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

TaiRx, Inc. has the following listings and related stock indices.


Stock: TWSE: 6580

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.